Probability analysis on associations of adverse drug events with drug-drug interactions

被引：0

作者：

Huang, Yu-Ting ^{[1
]}

Lin, Shih-Fang ^{[2
]}

Chiu, Chung-Cheng ^{[1
]}

Yeh, Hsiang-Yuan ^{[1
]}

Sooi, Von-Wun ^{[1
,2
,3
]}

机构：

[1] Natl Tsing Hua Univ, Dept Comp Sci, Hsinchu 300, Taiwan

[2] Natl Tsing Hua Univ, Inst Informat Syst & Applicat, Hsinchu 300, Taiwan

[3] Natl Univ Kaohsiung, Dept Comp Sci & Informat Engn, Kaohsiung 811, Taiwan

来源：

PROCEEDINGS OF THE 7TH IEEE INTERNATIONAL SYMPOSIUM ON BIOINFORMATICS AND BIOENGINEERING, VOLS I AND II | 2007年

关键词：

adverse drug reaction; probability analysis; association rules; drug-drug interactions;

D O I：

暂无

中图分类号：

R318 [生物医学工程];

学科分类号：

0831 ;

摘要：

Adverse drug reaction (ADR) may cost a lot of unnecessary medical resources and leads to extra suffering on patients. To provide the prompt information about ADR and avoid the rate of occurrence of ADR is an important task yet to be done. The US Food and Drug Administration (FDA) provides a Adverse Event Reporting System (AERS) which contains a lot of clinical reports about ADRs. However, the biologists still do not know precisely which observed events are directly caused by drug-drug interactions. We use the probability analysis method to find the associations between a set of drugs and the symptoms for predicting the ADR and apply the decision tree to discovery the association rules between the drug-drug interactions and symptoms.

引用

页码：1308 / +

页数：2

共 50 条

[1] PROBABILITY OF ADVERSE DRUG-DRUG INTERACTIONS IN MULTIPLE PRESCRIPTIONS
HEDDON, J
CORBETT, R
SOUTH AFRICAN JOURNAL OF SCIENCE, 1979, 75 (07) : 320 - 320
[2] Reducing harms: Focus on drug-drug interactions and adverse drug events
Citrome, Leslie
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2017, 71 (10)
[3] Potential Adverse Drug Events with Tetrahydrocannabinol (THC) Due to Drug-Drug Interactions
Brown, Joshua D.
JOURNAL OF CLINICAL MEDICINE, 2020, 9 (04)
[4] Systems pharmacology analysis of oncology drug combinations to evaluate adverse events due to drug-drug interactions
Kim, Sarah
Lahu, Gezim
Lesko, Lawrence J.
Trame, Mirjam N.
JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2016, 43 : S115 - S116
[5] Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use
Brown, Joshua D.
Winterstein, Almut G.
JOURNAL OF CLINICAL MEDICINE, 2019, 8 (07):
[6] Discrepancies in Reported Drug Use in Geriatric Outpatients: Relevance to Adverse Events and Drug-Drug Interactions
Tulner, Linda R.
Kuper, Ingeborg M. J. A.
Frankfort, Suzanne V.
van Campen, Jos P. C. M.
Koks, Cornelis H. W.
Brandies, Desiderius P. M.
Beijnen, Jos H.
AMERICAN JOURNAL OF GERIATRIC PHARMACOTHERAPY, 2009, 7 (02): : 93 - 104
[7] Adverse drug reactions related to drug-drug interactions: lower severity level of drug-drug interactions and pharmacodynamic interactions are oversighted
Kheloufi, F.
Duval, M.
Rouby, F.
Ponte, J.
Blin, O.
Default, A.
Micallef, J.
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2018, 32 : 89 - 89
[8] Network-Based Analysis and Characterization of Adverse Drug-Drug Interactions
Takarabe, Masataka
Shigemizu, Daichi
Kotera, Masaaki
Goto, Susumu
Kanehisa, Minoru
JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2011, 51 (11) : 2977 - 2985
[9] FLUOXETINE - ADVERSE-EFFECTS AND DRUG-DRUG INTERACTIONS
MESSIHA, FS
JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY, 1993, 31 (04): : 603 - 630
[10] Data mining for potential adverse drug-drug interactions
Hammann, Felix
Drewe, Juergen
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2014, 10 (05) : 665 - 671

← 1 2 3 4 5 →